약물 용출 스텐트 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)
Drug-Eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
상품코드:1742554
리서치사:Transparency Market Research
발행일:2025년 04월
페이지 정보:영문 205 Pages
라이선스 & 가격 (부가세 별도)
한글목차
약물 용출 스텐트 시장 - 조사 범위
TMR의 보고서 "세계 약물 용출 스텐트 시장"은 2025-2035년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2019년부터 2035년까지의 세계 약물 용출 스텐트 시장의 수익 및 예측을 제공하는데, 2025년은 기준 연도이며 2035년은 예측 연도로 간주됩니다. 또한, 2025-2035년까지의 세계 약물 용출 스텐트 시장의 연평균 성장률(CAGR %)을 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 약물 용출 스텐트 시장을 이해하고자 했습니다.
시장 현황
2024년 시장 규모
77억 달러
2035년 시장 규모
142억 달러
CAGR
5.7%
이 보고서는 세계 약물 용출 스텐트 시장의 경쟁 환경을 조사하고 있습니다. 세계 약물 용출 스텐트 시장에서 활동하는 주요 기업이 확인되었으며, 각 기업은 다양한 특성으로 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT는 세계 약물 용출 스텐트 시장 기업의 속성이며, 이 보고서에서 소개합니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약
제4장 시장 개요
소개
개요
시장 역학
세계의 약물 용출 스텐트 시장 분석과 예측, 2020-2035년
제5장 주요 인사이트
기술적 진보
Porter's Five Forces 분석
PESTEL 분석
공급망 분석
주요 업계 이벤트(합병, 인수, 제휴, 협업 등)
가격 분석(브랜드 가격, 지역/국가별 평균판매가격)
주요 국가·지역별 규제 시나리오
연구개발 동향
신규 시장 진입자를 위한 시장 개척 전략
제6장 세계의 시장 분석 및 예측 : 재료별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 재료별, 2020-2035년
금속
스테인리스강
코발트 크롬
니티놀
기타
폴리머
비생분해성 폴리머
생분해성 폴리머
시장 매력 분석 : 재료별
제7장 세계의 시장 분석 및 예측 : 약제별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 약제별, 2020-2035년
시롤리무스
파클리탁셀
조타롤리무스
에버롤리무스
기타
시장 매력 분석 : 약제별
제8장 세계의 시장 분석 및 예측 : 용도별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 용도별, 2020-2035년
관상동맥질환
말초동맥질환
기타
시장 매력 분석 : 용도별
제9장 세계의 시장 분석 및 예측 : 최종사용자별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 최종사용자별, 2020-2035년
병원
외래 수술 센터
기타
시장 매력 분석 : 최종사용자별
제10장 세계의 시장 분석 및 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별, 2020-2035년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 분석 : 지역별
제11장 북미의 시장 분석과 예측
제12장 유럽의 시장 분석과 예측
제13장 아시아태평양의 시장 분석과 예측
제14장 라틴아메리카의 시장 분석과 예측
제15장 중동 및 아프리카의 시장 분석과 예측
제16장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 계층별·규모별)
시장 점유율 분석 : 기업별(2024년)
기업 개요
Abbott Laboratories
AlviMedica
B. Braun Melsungen AG
Biosensors International Group, Ltd.
Shandong JW Medical Systems LTD.
Boston Scientific Corporation
Cook Medical Inc.
Elixir Medical Corp.
Lepu Medical Technology(Beijing) Co., Ltd.
Medtronic plc
Eurocor GmbH
OrbusNeich Medical Company Limited
Shanghai MicroPort Medical Co., Ltd.
Sino Medical Sciences Technology Inc.
KSM
영문 목차
영문목차
Drug-Eluting Stents Market - Scope of Report
TMR's report on the global drug-eluting stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug-eluting stents market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug-eluting stents market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug-eluting stents market.
Market Snapshot
Market Value in 2024
US$ 7.7 Bn
Market Value in 2035
US$ 14.2 Bn
CAGR
5.7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug-eluting stents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug-eluting stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug-eluting stents market.
The report delves into the competitive landscape of the global drug-eluting stents market. Key players operating in the global drug-eluting stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug-eluting stents market profiled in this report.
Key Questions Answered in global drug-eluting stents Market Report:
What is the sales/revenue generated by drug-eluting stents across all regions during the forecast period?
What are the opportunities in the global drug-eluting stents market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Drug-Eluting Stents Market - Research Objectives and Research Approach
The comprehensive report on the global drug-eluting stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global drug-eluting stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug-eluting stents market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-Eluting Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug-Eluting Stents Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological Advancements
5.2. PORTER's Five Forces Analysis
5.3. PESTEL Analysis
5.4. Supply Chain Analysis
5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
5.7. Regulatory Scenario by Key Country/Region
5.8. Research and Development Trends
5.9. Go-to-Market Strategy for New Market Entrants
6. Global Drug-Eluting Stents Market Analysis and Forecast, by Material
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Material, 2020-2035
6.3.1. Metal
6.3.1.1. Stainless-Steel
6.3.1.2. Cobalt-Chromium
6.3.1.3. Nitinol
6.3.1.4. Others
6.3.2. Polymer
6.3.2.1. Non-biodegradable Polymers
6.3.2.2. Biodegradable Polymers
6.4. Market Attractiveness Analysis, by Material
7. Global Drug-Eluting Stents Market Analysis and Forecast, by Drug
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug, 2020-2035
7.3.1. Sirolimus
7.3.2. Paclitaxel
7.3.3. Zotarolimus
7.3.4. Everolimus
7.3.5. Others
7.4. Market Attractiveness Analysis, by Drug
8. Global Drug-Eluting Stents Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application , 2020-2035
8.3.1. Coronary Artery Disease
8.3.2. Peripheral Artery Disease
8.3.3. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Drug-Eluting Stents Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Drug-Eluting Stents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Drug-Eluting Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Material, 2020-2035
11.2.1. Metal
11.2.1.1. Stainless-Steel
11.2.1.2. Cobalt-Chromium
11.2.1.3. Nitinol
11.2.1.4. Others
11.2.2. Polymer
11.2.2.1. Non-biodegradable Polymers
11.2.2.2. Biodegradable Polymers
11.3. Market Value Forecast, by Drug, 2020-2035
11.3.1. Sirolimus
11.3.2. Paclitaxel
11.3.3. Zotarolimus
11.3.4. Everolimus
11.3.5. Others
11.4. Market Value Forecast, by Application , 2020-2035
11.4.1. Coronary Artery Disease
11.4.2. Peripheral Artery Disease
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2020-2035
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country, 2020-2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Material
11.7.2. By Drug
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Drug-Eluting Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Material, 2020-2035
12.2.1. Metal
12.2.1.1. Stainless-Steel
12.2.1.2. Cobalt-Chromium
12.2.1.3. Nitinol
12.2.1.4. Others
12.2.2. Polymer
12.2.2.1. Non-biodegradable Polymers
12.2.2.2. Biodegradable Polymers
12.3. Market Value Forecast, by Drug, 2020-2035
12.3.1. Sirolimus
12.3.2. Paclitaxel
12.3.3. Zotarolimus
12.3.4. Everolimus
12.3.5. Others
12.4. Market Value Forecast, by Application , 2020-2035
12.4.1. Coronary Artery Disease
12.4.2. Peripheral Artery Disease
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2020-2035
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Material
12.7.2. By Drug
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Drug-Eluting Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Material, 2020-2035
13.2.1. Metal
13.2.1.1. Stainless-Steel
13.2.1.2. Cobalt-Chromium
13.2.1.3. Nitinol
13.2.1.4. Others
13.2.2. Polymer
13.2.2.1. Non-biodegradable Polymers
13.2.2.2. Biodegradable Polymers
13.3. Market Value Forecast, by Drug, 2020-2035
13.3.1. Sirolimus
13.3.2. Paclitaxel
13.3.3. Zotarolimus
13.3.4. Everolimus
13.3.5. Others
13.4. Market Value Forecast, by Application , 2020-2035
13.4.1. Coronary Artery Disease
13.4.2. Peripheral Artery Disease
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2020-2035
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Material
13.7.2. By Drug
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Drug-Eluting Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Material, 2020-2035
14.2.1. Metal
14.2.1.1. Stainless-Steel
14.2.1.2. Cobalt-Chromium
14.2.1.3. Nitinol
14.2.1.4. Others
14.2.2. Polymer
14.2.2.1. Non-biodegradable Polymers
14.2.2.2. Biodegradable Polymers
14.3. Market Value Forecast, by Drug, 2020-2035
14.3.1. Sirolimus
14.3.2. Paclitaxel
14.3.3. Zotarolimus
14.3.4. Everolimus
14.3.5. Others
14.4. Market Value Forecast, by Application , 2020-2035
14.4.1. Coronary Artery Disease
14.4.2. Peripheral Artery Disease
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2020-2035
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Material
14.7.2. By Drug
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Drug-Eluting Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Material, 2020-2035
15.2.1. Metal
15.2.1.1. Stainless-Steel
15.2.1.2. Cobalt-Chromium
15.2.1.3. Nitinol
15.2.1.4. Others
15.2.2. Polymer
15.2.2.1. Non-biodegradable Polymers
15.2.2.2. Biodegradable Polymers
15.3. Market Value Forecast, by Drug, 2020-2035
15.3.1. Sirolimus
15.3.2. Paclitaxel
15.3.3. Zotarolimus
15.3.4. Everolimus
15.3.5. Others
15.4. Market Value Forecast, by Application , 2020-2035
15.4.1. Coronary Artery Disease
15.4.2. Peripheral Artery Disease
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2020-2035
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Material
15.7.2. By Drug
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2024)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. AlviMedica
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. B. Braun Melsungen AG
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. Biosensors International Group, Ltd.
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. Shandong JW Medical Systems LTD.
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Boston Scientific Corporation
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. Cook Medical Inc.
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
16.3.8. Elixir Medical Corp.
16.3.8.1. Company Overview
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Business Strategies
16.3.8.5. Recent Developments
16.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
